Chemoradiation in nasopharyngeal carcinoma: a 6-year experience in Tehran cancer institute
Acta Medica Iranica. 2011; 49 (1): 49-53
em Inglês
| IMEMR
| ID: emr-124527
ABSTRACT
To determine the addition of value of neoadjuvant, concurrent and adjuvant chemotherapy to radiation in the treatment of nasopharyngeal carcinoma with regard to the overall survival [OS] and disease free survival [DPS] within a six year period in Tehran cancer institute. Files of all patients with nasopharyngeal carcinoma treated by radiotherapy with or without concurrent chemotherapy in a curative setting in Tehran cancer institute during the period of 1999-2005 were retrospectively reviewed. A total of 103 patients with nasopharyngeal carcinoma had been treated during the study period with radiotherapy or chemoradiotherapy in our institute. There were 29 [28.2%] females and 74 [71.8%] males. The median age at the time of radiotherapy was 47 years old [range 9-75 years]. The patients were followed 2 to 76 months with a median follow-up of 14 months. Time of first recurrence after treatment was 3-44 months with a median of 10 months. Survival in 2 groups of patients treated with radiotherapy alone or chemoradiation did not have a significant difference [P>0.1]. Two-year survival in patients treated with or without adjuvant chemotherapy and had local recurrence after treatment did not have significant difference [P>0.1]. Two-year survival in patients with or without local recurrence after treatment did not have significant difference [P>0.1]. A beneficial effect or a survival benefit of adjuvant/neoadjuvant chemotherapy and concurrent chemoradiation was not observed in Iranian patients
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Radioterapia
/
Sobrevida
/
Estudos Retrospectivos
/
Quimioterapia Adjuvante
/
Intervalo Livre de Doença
/
Terapia Neoadjuvante
/
Quimiorradioterapia
/
Antineoplásicos
Limite:
Feminino
/
Humanos
/
Masculino
Idioma:
Inglês
Revista:
Acta Med. Iran.
Ano de publicação:
2011
Similares
MEDLINE
...
LILACS
LIS